QS Capital

QS Capital is a principal investment firm based in Xiamen, China, established in 2015. The firm focuses on investing in sectors related to consumer goods, biopharmaceuticals, medical services, and emerging consumer trends. With a dedicated executive management team, QS Capital aims to identify high-quality opportunities within the consumption and medical technology industries, leveraging its expertise to navigate these evolving markets.

Huiqi Lin

Partner

Huihao Lin

Partner

Shikai Wang

Partner

Weize Xu

Partner

Yiwei Zeng

Partner

Damin Zhou

Partner

5 past transactions

magAssist

Series A in 2019
Suzhou MagAssist Medical Technology Co., Ltd. is a Chinese company specializing in the development of short and medium-term in vitro ventricular assist devices, commonly referred to as in vitro artificial hearts. Founded in 2016 and based in Suzhou, the company aims to provide innovative solutions for patients experiencing severe cardiovascular conditions, including those recovering from cardiopulmonary bypass and acute illnesses such as fulminant myocarditis and cardiac arrest. MagAssist focuses on integrating advanced fluid mechanics and magnetic suspension technology into its products to enhance compatibility with various blood types, thereby improving patient recovery outcomes. The company is recognized for its homegrown artificial heart technology, backed by a team of experts with extensive experience in artificial heart research and development.

XmeBank

Seed Round in 2017
XmeBank is a financial services platform based in Beijing, China, specializing in providing loans to businesses in the catering industry. The company leverages big data collection and analytics to enhance its services, facilitating access to loans and credit for restaurants. This approach aims to create a more transparent and efficient financing process for its clients, helping them secure the financial support they need to thrive in a competitive market.

Biosis Healing

Series C in 2017
Beijing Biosis Healing Biotechnology Co., Ltd. is a Chinese company founded in 2012, specializing in the research, development, production, and sales of biomaterial medical devices. The company focuses on regenerative medicine materials and implantable medical devices used in clinical surgery. Biosis Healing offers innovative products, including regenerative surgical biomaterials, implantable soft tissue repair mesh, and intelligent minimally invasive surgical instruments. A key product is their self-developed non-crosslinked Extracellular Matrix biomaterial, known as SIS material, which aids in the regeneration of tissue defects and provides effective solutions for tissue repair and functional regeneration following surgical procedures.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.